March 24, 2026

GoodRx Holdings, Inc. (GDRX): Investor Outlook Reveals 35% Potential Upside Amid Healthcare Tech Evolution

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the Health Information Services industry, continues to make waves in the healthcare sector with its innovative offerings aimed at reducing prescription..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 22.89% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) finds itself at a crossroads with a potential upside of 22.89%, sparking curiosity among investors eager for growth opportunities in the healthcare sector. With..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Unlocking Value with a Forward P/E of 8.86

Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider in the healthcare sector, particularly in the medical care facilities industry, offers a compelling investment opportunity with its strategic focus on..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring a 43% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) has emerged as a noteworthy player in the medical instruments and supplies industry, with a focus on pioneering bioelectric medicine. As an investor, understanding the..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring an 82.87% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO), a leading player in the diagnostics and research industry, offers investors an intriguing opportunity with a striking potential upside of 82.87%. Operating in the healthcare sector,..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Growth with a 5.24% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation in the health information services industry. With its cutting-edge platforms and technologies for analyzing biological systems, this California-based company..

Harrow, Inc. (HROW) Stock Analysis: A 103.68% Potential Upside in the Specialty Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector, has been making waves with its focus on ophthalmic pharmaceutical products. With a market cap of $1.27 billion, this..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 193% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company headquartered in Singapore, is generating significant buzz among investors with its promising pipeline and substantial potential upside. The company, which..

Astrana Health Inc. (ASTH) Stock Analysis: 51% Potential Upside Beckons Investors

Astrana Health Inc. (NASDAQ: ASTH) presents a compelling opportunity for investors in the healthcare sector, particularly those keen on medical care facilities. With a market capitalization of $1.32 billion, Astrana..

Progyny, Inc. (PGNY) Stock Analysis: 52.44% Potential Upside in the Fertility Benefits Space

Progyny, Inc. (NASDAQ: PGNY) is making waves in the healthcare sector with its innovative approach to fertility and family-building benefit solutions. With a market capitalization of $1.48 billion, this New..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 65.80% Potential Upside

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, presents an intriguing case for investors seeking growth potential. With a..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 94% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR), a key player in the healthcare sector, operates within the health information services industry with a unique approach that marries technology and drug development. Based in..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Unlocking Potential with 107.87% Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a dynamic player in the biotechnology sector, has been turning heads with its ambitious approach to drug discovery. While the current stock price sits at..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 61% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (SGRY), a prominent player in the healthcare sector, has caught the attention of investors with its intriguing potential upside of 61.44%, according to analyst ratings. This company,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Analyst Ratings Point to a Potential 223% Upside

Investors eyeing opportunities in the biotechnology sector might find Ocular Therapeutix, Inc. (NASDAQ: OCUL) an intriguing prospect, particularly given its compelling analyst ratings and potential upside. This Massachusetts-based biopharmaceutical company..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Aiming for a 58% Upside with Innovative Oncology Solutions

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine in oncology, captivating investor interest with a potential upside of 58.03% based on current analyst projections. With a..

Concentra Group Holdings (CON) Stock Analysis: A 29.64% Potential Upside Beckons Healthcare Investors

As investors continue to search for compelling opportunities in the healthcare sector, Concentra Group Holdings Parent (CON) stands out with a remarkable potential upside of 29.64%, according to recent analyst..

QuidelOrtho Corporation (QDEL) Stock Analysis: Unveiling a Potential 109% Upside in the Healthcare Sector

QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector, is making waves with its diagnostic testing solutions spread across its diversified business units. With a market capitalization of $1.13..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating Growth with a 17.4% Revenue Surge

Guardian Pharmacy Services, Inc. (GRDN) is carving a niche in the healthcare sector with its innovative approach to serving long-term care facilities (LTCFs) in the United States. As a provider..

Establishment Labs Holdings Inc (ESTA): Growth Potential and Investor Sentiment Amidst a 49.3% Upside

Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing investor attention with a substantial potential upside of 49.3%, according to analysts. The company, a key player in the healthcare sector, specifically..

Search

Funds

March 24, 2026

Search

Funds

March 24, 2026

FTSE 100

Funds